High-dose-rate brachytherapy as monotherapy for localized prostate cancer using three different doses – 14 years of single-centre experience

PURPOSE: To evaluate clinical outcomes in patients with localized prostate cancer (LPC) treated with 3D conformal high-dose-rate (HDR) brachytherapy (BT) as monotherapy. MATERIAL AND METHODS: From March 2004 to November 2017, 277 men with LPC underwent 3D conformal HDR-BT as monotherapy, with a temp...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Contemp Brachytherapy
Päätekijät: Soatti, Carlo Pietro, Delishaj, Durim, D’Amico, Romerai, Frigerio, Cristina, Fumagalli, Ilaria Costanza, Bonsignore, Francesco, Sangalli, Giulia, Declich, Fausto, Arcangeli, Stefano, Ardizzoia, Antonio, Colombo, Alessandro
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Termedia Publishing House 2020
Aiheet:
Original Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7787203/
https://ncbi.nlm.nih.gov/pubmed/33437300
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/jcb.2020.101685
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia